Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
PLoS One
    January 2022
  1. KONDO T, Koroki K, Kanzaki H, Kobayashi K, et al
    Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.
    PLoS One. 2022;17:e0261619.
    >> Share

  2. THOMAS KL, Root CL, Peterson JM
    Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
    PLoS One. 2022;17:e0258557.
    >> Share

  3. DRESSEL-BOHM S, Richter H, Kircher PR, Del Chicca F, et al
    Hypoattenuating periportal halo on CT in a patient population can occur in presence of a variety of diseases.
    PLoS One. 2022;17:e0260436.
    >> Share

  4. KIM KE, Sinn DH, Choi MS, Kim H, et al
    Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment.
    PLoS One. 2022;17:e0262750.
    >> Share

  5. ABDALLAH HMI, El Awdan SA, Abdel-Rahman RF, Farrag ARH, et al
    1,8 Cineole and Ellagic acid inhibit hepatocarcinogenesis via upregulation of MiR-122 and suppression of TGF-beta1, FSCN1, Vimentin, VEGF, and MMP-9.
    PLoS One. 2022;17:e0258998.
    >> Share

  6. DU Y, Cortez A, Josefsson A, Zarisfi M, et al
    Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.
    PLoS One. 2022;17:e0261982.
    >> Share

  7. LIU X, Taylor SA, Gromer KD, Zhang D, et al
    Mechanisms of liver injury in high fat sugar diet fed mice that lack hepatocyte X-box binding protein 1.
    PLoS One. 2022;17:e0261789.
    >> Share

  8. MEIJER TS, Dieters JHN, de Leede EM, de Geus-Oei LF, et al
    Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
    PLoS One. 2022;17:e0261939.
    >> Share

  9. RADFORD-SMITH DE, Patel PJ, Irvine KM, Russell A, et al
    Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.
    PLoS One. 2022;17:e0261555.
    >> Share

  10. BRAUNWARTH E, Schullian P, Kummann M, Reider S, et al
    Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
    PLoS One. 2022;17:e0261136.
    >> Share

  11. MIZUNO H, Sekine A, Suwabe T, Ikuma D, et al
    Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use.
    PLoS One. 2022;17:e0264065.
    >> Share

  12. KIM SS, Kycia I, Karski M, Ma RK, et al
    DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling.
    PLoS One. 2022;17:e0263829.
    >> Share

  13. SANSILVESTRI MOREL P, Duvivier V, Bertin F, Provost N, et al
    Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression.
    PLoS One. 2022;17:e0263828.
    >> Share

  14. ASADULLAH M, Shivashankar R, Shalimar, Kandasamy D, et al
    Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.
    PLoS One. 2022;17:e0263768.
    >> Share

  15. YAN J, Huang QY, Huang YJ, Wang CS, et al
    SPATS2 is positively activated by long noncoding RNA SNHG5 via regulating DNMT3a expression to promote hepatocellular carcinoma progression.
    PLoS One. 2022;17:e0262262.
    >> Share

  16. ROH JH, Lee H, Yun-Jeong B, Park CS, et al
    A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.
    PLoS One. 2022;17:e0262715.
    >> Share

  17. KANMANI P, Kim H
    Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-beta/SMAD signaling and autophagy in hepatic stellate cells.
    PLoS One. 2022;17:e0262767.
    >> Share

  18. YAMAOKA K, Kodama K, Kawaoka T, Kosaka M, et al
    The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
    PLoS One. 2022;17:e0262675.
    >> Share

  19. LAI HF, Chau IY, Lei HJ, Chou SC, et al
    Postoperative fever after liver resection: Incidence, risk factors, and characteristics associated with febrile infectious complication.
    PLoS One. 2022;17:e0262113.
    >> Share

  20. MATSUSHIMA-NISHIWAKI R, Yamada N, Hattori Y, Hosokawa Y, et al
    SERMs (selective estrogen receptor modulator), acting as estrogen receptor beta agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-alpha-induced migration via specific inhibition of AKT signaling pathway.
    PLoS One. 2022;17:e0262485.
    >> Share

  21. FERNANDEZ T, Vinuela M, Vidal C, Barrera F, et al
    Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263931.
    >> Share

  22. STOFFERS P, Guckenbiehl S, Welker MW, Zeuzem S, et al
    Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation.
    PLoS One. 2022;17:e0263989.
    >> Share

  23. SUWIMOL S, Pisit T, Anchalee A, Narisorn K, et al
    Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand.
    PLoS One. 2022;17:e0263826.
    >> Share

  24. RATNASARI N, Lestari P, Renovaldi D, Raditya Ningsih J, et al
    Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.
    PLoS One. 2022;17:e0263298.
    >> Share

  25. LIU L, Fu Q, Li T, Shao K, et al
    Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.
    PLoS One. 2022;17:e0262855.
    >> Share

  26. YOKOYAMA K, Sakamaki A, Takahashi K, Naruse T, et al
    Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function.
    PLoS One. 2022;17:e0264459.
    >> Share

  27. MORISHITA A, Tadokoro T, Fujihara S, Iwama H, et al
    Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
    PLoS One. 2022;17:e0261310.
    >> Share

  28. ARNEY J, Gray C, Clark JA, Smith D, et al
    Prognosis conversations in advanced liver disease: A qualitative interview study with health professionals and patients.
    PLoS One. 2022;17:e0263874.
    >> Share

  29. MILES LF, Couture EJ, Potes C, Makar T, et al
    Preliminary experience with continuous right ventricular pressure and transesophageal echocardiography monitoring in orthotopic liver transplantation.
    PLoS One. 2022;17:e0263386.
    >> Share

  30. SAKAMAKI A, Takamura M, Sakai N, Watanabe Y, et al
    Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis.
    PLoS One. 2022;17:e0263464.
    >> Share

  31. LE BOUTILLIER C, Snowdon C, Patel V, McPhail M, et al
    Using a theory-informed approach to explore patient and staff perspectives on factors that influence clinical trial recruitment for patients with cirrhosis and small oesophageal varices.
    PLoS One. 2022;17:e0263288.
    >> Share

  32. SARMADI N, Poustchi H, Ali Yari F, Radmard AR, et al
    Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease.
    PLoS One. 2022;17:e0266227.
    >> Share

  33. KADDU-MULINDWA D, von Martial M, Thiel-Bodenstaff A, Lesan V, et al
    Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization.
    PLoS One. 2022;17:e0266069.
    >> Share

  34. KIM D, Kim JH, Ko DR, Min IK, et al
    Usefulness of contrast-enhanced multi-detector computed tomography in identifying upper gastrointestinal bleeding: A retrospective study of patients admitted to the emergency department.
    PLoS One. 2022;17:e0266622.
    >> Share

  35. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
    Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
    PLoS One. 2022;17:e0266505.
    >> Share

  36. CAROL M, Perez-Guasch M, Sola E, Cervera M, et al
    Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
    PLoS One. 2022;17:e0265153.
    >> Share

  37. HAYASHI R, Kogiso T, Kikuchi N, Yamamoto K, et al
    Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates.
    PLoS One. 2022;17:e0267125.
    >> Share

  38. WORETA TA, Van Natta ML, Lazo M, Krishnan A, et al
    Validation of the accuracy of the FAST score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
    PLoS One. 2022;17:e0266859.
    >> Share

  39. SALMAN M, Kamel MA, El-Nabi SEH, Ismail AHA, et al
    The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis.
    PLoS One. 2022;17:e0265455.
    >> Share

  40. GHOSH A, Sarmah P, Patel H, Mukerjee N, et al
    Nonlinear molecular dynamics of quercetin in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection.
    PLoS One. 2022;17:e0263917.
    >> Share

  41. NAKAZAWA M, Imai Y, Sugawara K, Uchida Y, et al
    Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices.
    PLoS One. 2022;17:e0264359.
    >> Share

  42. FU J, Gao Y, Shi L
    Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267647.
    >> Share

  43. ISHII M, Itano O, Morinaga J, Shirakawa H, et al
    Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
    PLoS One. 2022;17:e0266707.
    >> Share

  44. GAIRING SJ, Galle PR, Schattenberg JM, Kostev K, et al
    Portal vein thrombosis is associated with an increased risk of bone fractures.
    PLoS One. 2022;17:e0267535.
    >> Share

  45. NGUYEN TB, Do DN, Nguyen TTP, Nguyen TL, et al
    Immune-related biomarkers shared by inflammatory bowel disease and liver cancer.
    PLoS One. 2022;17:e0267358.
    >> Share

  46. CHEN PC, Lee YC, Su YC, Lee CH, et al
    Does hepatectomy improve outcomes of breast cancer with liver metastasis? A nationwide analysis of real-world data in Taiwan.
    PLoS One. 2022;17:e0266960.
    >> Share

  47. BAEK M, Chai JC, Choi HI, Yoo E, et al
    Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells.
    PLoS One. 2022;17:e0266966.
    >> Share

  48. GOLD LC, Macpherson I, Nobes JH, Dow E, et al
    Thrombocytosis and abnormal liver enzymes: A trigger for investigation of underlying malignancy.
    PLoS One. 2022;17:e0267124.
    >> Share

  49. HU S, Zhang J, Guo G, Zhang L, et al
    Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma.
    PLoS One. 2022;17:e0267117.
    >> Share

  50. MEZO M, Gonzalez-Warleta M, Castro-Hermida JA, Martinez-Sernandez V, et al
    Field evaluation of the enhanced MM3-COPRO ELISA test for the diagnosis of Fasciola hepatica infection in sheep.
    PLoS One. 2022;17:e0265569.
    >> Share

  51. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
    Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2022;17:e0265461.
    >> Share

  52. PENG CH, Ker YB, Li HH, Tsou SH, et al
    Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4-With improving insulin resistance.
    PLoS One. 2022;17:e0265444.
    >> Share

  53. KANEKO S, Kurosaki M, Tsuchiya K, Yasui Y, et al
    Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.
    PLoS One. 2022;17:e0265235.
    >> Share

  54. GRASS JK, Kusters N, Kemper M, Tintrup J, et al
    Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.
    PLoS One. 2022;17:e0265093.
    >> Share

  55. SAXENA R, Nassiri M, Yin XM, Morral N, et al
    Insights from a high-fat diet fed mouse model with a humanized liver.
    PLoS One. 2022;17:e0268260.
    >> Share

  56. HICKMAN TL, Choi E, Whiteman KR, Muralidharan S, et al
    BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity.
    PLoS One. 2022;17:e0266980.
    >> Share

  57. OH MK, Joo H, Kim IS
    Prohaptoglobin inhibits the transforming growth factor-beta-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
    PLoS One. 2022;17:e0266409.
    >> Share

  58. ORR CE, Wang PL, Chen L, Wang T, et al
    Features of fibrosis regression abound in "non-cirrhotic" patients with resected hepatocellular carcinoma.
    PLoS One. 2022;17:e0267474.
    >> Share

  59. MUCKE VT, Peiffer KH, Kessel J, Schwarzkopf KM, et al
    Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding.
    PLoS One. 2022;17:e0268638.
    >> Share

  60. ZHANG XF, Lai L, Zhou H, Mo YJ, et al
    Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis.
    PLoS One. 2022;17:e0268779.
    >> Share

  61. BESSHO R, Kashiwagi K, Ikura A, Yamataka K, et al
    A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.
    PLoS One. 2022;17:e0269265.
    >> Share

  62. WANG L, Ding Y, Zhang C, Chen R, et al
    Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
    PLoS One. 2022;17:e0269249.
    >> Share

  63. THEVENOT T, Vendeville S, Weil D, Akkouche L, et al
    Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study.
    PLoS One. 2022;17:e0266965.
    >> Share

  64. LAUN FB, Fuhres T, Seuss H, Muller A, et al
    Flow-compensated diffusion encoding in MRI for improved liver metastasis detection.
    PLoS One. 2022;17:e0268843.
    >> Share

  65. RIDJAB DA, Ivan I, Budiman F, Tenggara R, et al
    Evaluation of subclinical ventricular systolic dysfunction assessed using global longitudinal strain in liver cirrhosis: A systematic review, meta-analysis, and meta-regression.
    PLoS One. 2022;17:e0269691.
    >> Share

  66. EFREMOV Y, Ermolaeva A, Vladimirov G, Gordleeva S, et al
    A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.
    PLoS One. 2022;17:e0264903.
    >> Share

  67. LYNCH EC, Liu Z, Liu L, Wang X, et al
    Disrupting Osr1 expression promoted hepatic steatosis and inflammation induced by high-fat diet in the mouse model.
    PLoS One. 2022;17:e0268344.
    >> Share

  68. PARK J, Kwon HJ, Sohn W, Cho JY, et al
    Risk of liver fibrosis in patients with prediabetes and diabetes mellitus.
    PLoS One. 2022;17:e0269070.
    >> Share

  69. KOGISO T, Sagawa T, Taniai M, Shimada E, et al
    Risk factors for Fontan-associated hepatocellular carcinoma.
    PLoS One. 2022;17:e0270230.
    >> Share

  70. NABILOU P, Danielsen KV, Kimer N, Hove JD, et al
    Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
    PLoS One. 2022;17:e0270603.
    >> Share

  71. GUL B, Firasat S, Tehreem R, Shan T, et al
    Analysis of Wilson disease mutations in copper binding domain of ATP7B gene.
    PLoS One. 2022;17:e0269833.
    >> Share

  72. LO B, Marty-Gasset N, Manse H, Canlet C, et al
    Slightly different metabolomic profiles are associated with high or low weight duck foie gras.
    PLoS One. 2022;17:e0255707.
    >> Share

  73. HUANG YJ, Wang PM, Tang KS, Chen CJ, et al
    Butyrate ameliorates maternal high-fat diet-induced fetal liver cellular apoptosis.
    PLoS One. 2022;17:e0270657.
    >> Share

  74. ZUO Z, Cui H, Wang M, Huang C, et al
    Diagnostic of FibroTouch and six serological models in assessing the degree of liver fibrosis among patients with chronic hepatic disease: A single-center retrospective study.
    PLoS One. 2022;17:e0270512.
    >> Share

  75. NAKAI M, Suda G, Ogawa K, Yoshida S, et al
    Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
    PLoS One. 2022;17:e0270786.
    >> Share

  76. NAGASAWA T, Kuroda H, Abe T, Saiki H, et al
    Shear wave dispersion to assess liver disease progression in Fontan-associated liver disease.
    PLoS One. 2022;17:e0271223.
    >> Share

  77. TASCON-VIDARTE JD, Stick LB, Josipovic M, Risum S, et al
    Accuracy and consistency of intensity-based deformable image registration in 4DCT for tumor motion estimation in liver radiotherapy planning.
    PLoS One. 2022;17:e0271064.
    >> Share

  78. KIM N, Roh JH, Lee H, Kim D, et al
    The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: A nationwide study of Korea.
    PLoS One. 2022;17:e0271021.
    >> Share

  79. WEHMEYER MH, Sekhri H, Wroblewski R, Galante A, et al
    Frequent detection of functional hyposplenism via assessment of pitted erythrocytes in patients with advanced liver cirrhosis.
    PLoS One. 2022;17:e0271541.
    >> Share

  80. COKER T, Saxton J, Retat L, Alswat K, et al
    The future health and economic burden of obesity-attributable type 2 diabetes and liver disease among the working-age population in Saudi Arabia.
    PLoS One. 2022;17:e0271108.
    >> Share

  81. DARADICS N, Horvath G, Tretter L, Paal A, et al
    The effect of Cyclophilin D depletion on liver regeneration following associating liver partition and portal vein ligation for staged hepatectomy.
    PLoS One. 2022;17:e0271606.
    >> Share

  82. JIANG Y, Zhang Y, Yang Q, Zeng D, et al
    The association between fetal fraction and pregnancy-related complications among Chinese population.
    PLoS One. 2022;17:e0271219.
    >> Share

  83. JANG S, Choi GH, Chang W, Jang ES, et al
    Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
    PLoS One. 2022;17:e0271407.
    >> Share

  84. GLOWCZYNSKA R, Borodzicz-Jazdzyk S, Peller M, Raszeja-Wyszomirska J, et al
    Chronotropic incompetence in end-stage liver disease.
    PLoS One. 2022;17:e0270784.
    >> Share

  85. ABDULMALEK S, Mostafa N, Gomaa M, El-Kersh M, et al
    Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
    PLoS One. 2022;17:e0272776.
    >> Share

  86. CULP WTN, Johnson EG, Giuffrida MA, Rebhun RB, et al
    Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs.
    PLoS One. 2022;17:e0269941.
    >> Share

    January 2021
  87. SPOGIS J, Hagen F, Thaiss WM, Hoffmann T, et al
    Sonographic findings in coronavirus disease-19 associated liver damage.
    PLoS One. 2021;16:e0244781.
    >> Share

  88. OHIRA S, Kanayama N, Wada K, Ikawa T, et al
    Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography.
    PLoS One. 2021;16:e0244079.
    >> Share

  89. ZHAO N, Tan H, Wang L, Han L, et al
    Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes.
    PLoS One. 2021;16:e0243938.
    >> Share

  90. SETO WK, Mandell MS
    Chronic liver disease: Global perspectives and future challenges to delivering quality health care.
    PLoS One. 2021;16:e0243607.
    >> Share

  91. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West.
    PLoS One. 2021;16:e0244939.
    >> Share

  92. LI X, Zhong X, Wang Y, Zeng X, et al
    Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250602.
    >> Share

  93. FERSTL PG, Filmann N, Heilgenthal EM, Schnitzbauer AA, et al
    Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.
    PLoS One. 2021;16:e0245091.
    >> Share

  94. DA FONSECA RD, Santos PR, Monteiro MS, Fernandes LA, et al
    Parametric evaluation of impedance curve in radiofrequency ablation: A quantitative description of the asymmetry and dynamic variation of impedance in bovine ex vivo model.
    PLoS One. 2021;16:e0245145.
    >> Share

  95. FRANKOVA S, Lunova M, Gottfriedova H, Senkerikova R, et al
    Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.
    PLoS One. 2021;16:e0244934.
    >> Share

  96. WANG F, Numata K, Takeda A, Ogushi K, et al
    Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma.
    PLoS One. 2021;16:e0245076.
    >> Share

  97. CARTER JK, Bhattacharya D, Borgerding JN, Fiel MI, et al
    Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.
    PLoS One. 2021;16:e0244763.
    >> Share

  98. JOBIRA B, Frank DN, Silveira LJ, Pyle L, et al
    Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
    PLoS One. 2021;16:e0245219.
    >> Share

  99. FATTAHI N, Rezaei N, Asadi-Lari M, Yousefi M, et al
    Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.
    PLoS One. 2021;16:e0245468.
    >> Share

  100. VAN AMERONGEN MJ, Vos AM, van der Woude W, Nagtegaal ID, et al
    Does perfusion computed tomography correlate to pathology in colorectal liver metastases?
    PLoS One. 2021;16:e0245764.
    >> Share

  101. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    >> Share

  102. CHO Y, Lee S, Park SJ
    Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    PLoS One. 2021;16:e0245911.
    >> Share

  103. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    >> Share

  104. CHEN BW, Chiu GW, He YC, Huang CY, et al
    Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid.
    PLoS One. 2021;16:e0245286.
    >> Share

  105. NIRIELLA MA, Ediriweera DS, Kasturiratne A, De Silva ST, et al
    Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.
    PLoS One. 2021;16:e0245762.
    >> Share

  106. MENDOZA N, Rivas E, Rodriguez-Roisin R, Garcia T, et al
    Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.
    PLoS One. 2021;16:e0245046.
    >> Share

  107. VOGL TJ, Riegelbauer LJ, Oppermann E, Kostantin M, et al
    Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma.
    PLoS One. 2021;16:e0246527.
    >> Share

  108. SEO N, Park MS, Choi JY, Yeom JS, et al
    A prospective study on the use of ultralow-dose computed tomography with iterative reconstruction for the follow-up of patients liver and renal abscess.
    PLoS One. 2021;16:e0246532.
    >> Share

  109. ASSIS JB, Cogliati B, Esteves E, Capurro ML, et al
    Aedes aegypti mosquito saliva ameliorates acetaminophen-induced liver injury in mice.
    PLoS One. 2021;16:e0245788.
    >> Share

  110. TANAKA T, Hirooka M, Koizumi Y, Watanabe T, et al
    Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method.
    PLoS One. 2021;16:e0246315.
    >> Share

  111. KIM YA, Kang D, Moon H, Sinn D, et al
    Survival in untreated hepatocellular carcinoma: A national cohort study.
    PLoS One. 2021;16:e0246143.
    >> Share

  112. FUKUYAMA K, Asagiri M, Sugimoto M, Tsushima H, et al
    Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
    PLoS One. 2021;16:e0245939.
    >> Share

  113. STAHLSCHMIDT FL, Tafarel JR, Menini-Stahlschmidt CM, Baena CP, et al
    Hepatorenal index for grading liver steatosis with concomitant fibrosis.
    PLoS One. 2021;16:e0246837.
    >> Share

  114. TOMITA K, Chiba N, Ochiai S, Gunji T, et al
    Prognostic value of future liver remnant LU15 index of 99mTc-galactosyl serum albumin scintigraphy for predicting posthepatectomy liver failure.
    PLoS One. 2021;16:e0247675.
    >> Share

  115. KOVAC JD, Dakovic M, Jankovic A, Mitrovic M, et al
    The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    PLoS One. 2021;16:e0247301.
    >> Share

  116. KIMANYA ME, Routledge MN, Mpolya E, Ezekiel CN, et al
    Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data.
    PLoS One. 2021;16:e0247281.
    >> Share

  117. CHO WR, Wang CC, Tsai MY, Chou CK, et al
    Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.
    PLoS One. 2021;16:e0247231.
    >> Share

  118. POMEJ K, Scheiner B, Hartl L, Balcar L, et al
    COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
    PLoS One. 2021;16:e0256544.
    >> Share

  119. SHIGESAWA T, Suda G, Kimura M, Maehara O, et al
    Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.
    PLoS One. 2021;16:e0247728.
    >> Share

  120. NAKADE Y, Kitano R, Sakamoto K, Kimoto S, et al
    Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    PLoS One. 2021;16:e0247303.
    >> Share

  121. TAKASE T, Toyoda T, Kobayashi N, Inoue T, et al
    Dietary iso-alpha-acids prevent acetaldehyde-induced liver injury through Nrf2-mediated gene expression.
    PLoS One. 2021;16:e0246327.
    >> Share

  122. HODEIFY R, Chakkour M, Rida R, Kreydiyyeh S, et al
    PGE2 upregulates the Na+/K+ ATPase in HepG2 cells via EP4 receptors and intracellular calcium.
    PLoS One. 2021;16:e0245400.
    >> Share

  123. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
    Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
    PLoS One. 2021;16:e0249493.
    >> Share

  124. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
    The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2021;16:e0249614.
    >> Share

  125. BUSQUETS-CORTES C, Bennasar-Veny M, Lopez-Gonzalez AA, Fresneda S, et al
    Utility of Fatty Liver Index to predict reversion to normoglycemia in people with prediabetes.
    PLoS One. 2021;16:e0249221.
    >> Share

  126. BEYER C, Hutton C, Andersson A, Imajo K, et al
    Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.
    PLoS One. 2021;16:e0249491.
    >> Share

  127. KAPS L, Ahlbrand CJ, Gadban R, Nagel M, et al
    Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    PLoS One. 2021;16:e0249342.
    >> Share

  128. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
    Assessment of the association between body composition and risk of non-alcoholic fatty liver.
    PLoS One. 2021;16:e0249223.
    >> Share

  129. CHEN Y, Xu Z, Zeng Y, Liu J, et al
    Altered metabolism by autophagy defection affect liver regeneration.
    PLoS One. 2021;16:e0250578.
    >> Share

  130. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
    Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    PLoS One. 2021;16:e0250337.
    >> Share

  131. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
    What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250385.
    >> Share

  132. NAYAN SI, Chowdhury FI, Akter N, Rahman MM, et al
    Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats.
    PLoS One. 2021;16:e0250261.
    >> Share

  133. WANG R, Hu X, Liu X, Bai L, et al
    Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    PLoS One. 2021;16:e0249881.
    >> Share

  134. PARK JW, Jeong JM, Cho KS, Cho SY, et al
    MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases.
    PLoS One. 2021;16:e0250083.
    >> Share

  135. HOSHI H, Chu PS, Yoshida A, Taniki N, et al
    Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
    PLoS One. 2021;16:e0250062.
    >> Share

  136. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    >> Share

  137. MAHRINGER-KUNZ A, Steinle V, Kloeckner R, Schotten S, et al
    The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
    PLoS One. 2021;16:e0249426.
    >> Share

  138. NG YZ, Lai LL, Wong SW, Mohamad SY, et al
    Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.
    PLoS One. 2021;16:e0250300.
    >> Share

  139. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    >> Share

  140. SAEKI C, Saito M, Kanai T, Nakano M, et al
    Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.
    PLoS One. 2021;16:e0249728.
    >> Share

  141. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    >> Share

  142. KEHL T, Biermann D, Briem-Richter A, Schoen G, et al
    Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease.
    PLoS One. 2021;16:e0248776.
    >> Share

  143. LIN SY, Chen CM, Huang BS, Lai YC, et al
    A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness.
    PLoS One. 2021;16:e0249003.
    >> Share

  144. MISHIMA K, Itano O, Matsuda S, Suzuki S, et al
    Development of human hepatocellular carcinoma in X-linked severe combined immunodeficient pigs: An orthotopic xenograft model.
    PLoS One. 2021;16:e0248352.
    >> Share

  145. HUANG CY, Chang YJ, Wei PL, Hung CS, et al
    Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.
    PLoS One. 2021;16:e0248521.
    >> Share

  146. LOOSEN SH, Castoldi M, Jordens MS, Roy S, et al
    Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.
    PLoS One. 2021;16:e0247917.
    >> Share

  147. DE MUNCK TJI, Boesch M, Verhaegh P, Masclee AAM, et al
    Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    PLoS One. 2021;16:e0251822.
    >> Share

  148. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.
    PLoS One. 2021;16:e0249194.
    >> Share

  149. LEMIEUX S, Buies A, F Turgeon A, Hallet J, et al
    Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0247958.
    >> Share

  150. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
    Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0249164.
    >> Share

  151. JUSTINO AB, Florentino RM, Franca A, Filho ACML, et al
    Alkaloid and acetogenin-rich fraction from Annona crassiflora fruit peel inhibits proliferation and migration of human liver cancer HepG2 cells.
    PLoS One. 2021;16:e0250394.
    >> Share

  152. ZHANG X, Heredia NI, Balakrishnan M, Thrift AP, et al
    Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
    PLoS One. 2021;16:e0252164.
    >> Share

  153. BERNARDO S, Crespo R, Saraiva S, Barata R, et al
    Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality.
    PLoS One. 2021;16:e0252218.
    >> Share

  154. BROERING D, Shawkat M, Albenmousa A, Abaalkhail F, et al
    Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
    PLoS One. 2021;16:e0251487.
    >> Share

  155. PEREIRA R, Buglevski M, Perdigoto R, Marcelino P, et al
    Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care.
    PLoS One. 2021;16:e0251498.
    >> Share

  156. YOUNG P, Tarce P, Adhikary S, Connolly J, et al
    Evaluation of high-resolution melt curve analysis for rapid differentiation of Campylobacter hepaticus from other species in birds.
    PLoS One. 2021;16:e0251328.
    >> Share

  157. HE Y, Xu R, Peng L, Hu X, et al
    Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis.
    PLoS One. 2021;16:e0254829.
    >> Share

  158. DAYTON KA, Bril F, Barb D, Lai J, et al
    Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    PLoS One. 2021;16:e0251449.
    >> Share

  159. KAPS L, Hildebrand K, Nagel M, Michel M, et al
    Risk factors for poorer health literacy in patients with liver cirrhosis.
    PLoS One. 2021;16:e0255349.
    >> Share

  160. LEE Y, Mun E, Park S, Lee W, et al
    Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
    PLoS One. 2021;16:e0255118.
    >> Share

  161. HALFON P, Ansaldi C, Penaranda G, Chiche L, et al
    Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results.
    PLoS One. 2021;16:e0254939.
    >> Share

  162. KHORPRASERT C, Thonglert K, Alisanant P, Amornwichet N, et al
    Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes.
    PLoS One. 2021;16:e0257556.
    >> Share

  163. WEN X, Wang S, Taveira TH, Akhlaghi F, et al
    Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
    PLoS One. 2021;16:e0251665.
    >> Share

  164. COUBARD OA, Ober KM, Gaumet M, Urbanski M, et al
    Standardization of the psychometric hepatic encephalopathy score in a French population.
    PLoS One. 2021;16:e0257136.
    >> Share

  165. CHANG Y, Han JA, Kang SM, Jeong SW, et al
    Clinical impact of serum exosomal microRNA in liver fibrosis.
    PLoS One. 2021;16:e0255672.
    >> Share

  166. GAO L, Morine Y, Yamada S, Saito Y, et al
    Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
    PLoS One. 2021;16:e0256755.
    >> Share

  167. WAQAR W, Asghar S, Manzoor S
    Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    PLoS One. 2021;16:e0256739.
    >> Share

  168. STRUCK MF, Kliem P, Ebel S, Bauer A, et al
    Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery.
    PLoS One. 2021;16:e0254817.
    >> Share

  169. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    >> Share

  170. SHI X, Li J, Min B, Yang R, et al
    Application of ultrasound elastography for monitoring the effects of TbetaR1 shRNA therapy on hepatic fibrosis in a rat model.
    PLoS One. 2021;16:e0253150.
    >> Share

  171. SHIMIZU Y, Sasaki T, Takeshita JI, Watanabe M, et al
    Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
    PLoS One. 2021;16:e0253855.
    >> Share

  172. LEE JW, Hwang JS, Chung WJ, Lee HJ, et al
    Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.
    PLoS One. 2021;16:e0253886.
    >> Share

  173. REIMER RP, Hokamp NG, Niehoff J, Zopfs D, et al
    Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.
    PLoS One. 2021;16:e0252678.
    >> Share

  174. JO HH, Min C, Kyoung DS, Park MA, et al
    Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study.
    PLoS One. 2021;16:e0253165.
    >> Share

  175. TIYARATTANACHAI T, Apiparakoon T, Marukatat S, Sukcharoen S, et al
    Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images.
    PLoS One. 2021;16:e0252882.
    >> Share

  176. ROUNIS K, Makrakis D, Papadaki C, Monastirioti A, et al
    Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
    PLoS One. 2021;16:e0252537.
    >> Share

  177. ZHOU J, Zhu Y, Ma S, Li Y, et al
    Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma.
    PLoS One. 2021;16:e0258797.
    >> Share

  178. XIE Y, Liu C, Zhang Y, Li A, et al
    PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair.
    PLoS One. 2021;16:e0258817.
    >> Share

  179. HSU PK, Wu LS, Su WW, Su PY, et al
    Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
    PLoS One. 2021;16:e0254892.
    >> Share

  180. ISOURA Y, Yamamoto A, Cho Y, Ehara E, et al
    Platelet count and abdominal dynamic CT are useful in predicting and screening for gastroesophageal varices after Fontan surgery.
    PLoS One. 2021;16:e0257441.
    >> Share

  181. WANG Y, Xiao X, Wang X, Guo F, et al
    Identification of differentially expressed long noncoding RNAs and pathways in liver tissues from rats with hepatic fibrosis.
    PLoS One. 2021;16:e0258194.
    >> Share

  182. KHAMIS ZI, Pang X, Cui Z, Sang QA, et al
    Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity.
    PLoS One. 2021;16:e0257072.
    >> Share

  183. CHUAYPEN N, Limothai U, Kunadirek P, Kaewsapsak P, et al
    Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis.
    PLoS One. 2021;16:e0257805.
    >> Share

  184. PARK JH, Chung YE, Seo N, Choi JY, et al
    Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.
    PLoS One. 2021;16:e0257308.
    >> Share

  185. LI M, Hu M, Yue Z, Zhang Y, et al
    The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    PLoS One. 2021;16:e0257391.
    >> Share

  186. BHATT SP, Guleria R
    Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians.
    PLoS One. 2021;16:e0245408.
    >> Share

  187. HUNOLD P, Berg T, Seehofer D, Sucher R, et al
    Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics.
    PLoS One. 2021;16:e0254219.
    >> Share

  188. YANG CJ, Wang CK, Fang YD, Wang JY, et al
    Clinical application of mask region-based convolutional neural network for the automatic detection and segmentation of abnormal liver density based on hepatocellular carcinoma computed tomography datasets.
    PLoS One. 2021;16:e0255605.
    >> Share

  189. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
    Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
    PLoS One. 2021;16:e0254500.
    >> Share

  190. WU PS, Hsieh YC, Lee KC, Huang YH, et al
    Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
    PLoS One. 2021;16:e0258589.
    >> Share

  191. KOO DJ, Lee MY, Jung I, Moon SJ, et al
    Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
    PLoS One. 2021;16:e0255535.
    >> Share

  192. TRAN BV, Ujita K, Taketomi-Takahashi A, Hirasawa H, et al
    Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    PLoS One. 2021;16:e0255768.
    >> Share

  193. KITAZAWA A, Maeda S, Fukuda Y
    Fatty liver index as a predictive marker for the development of diabetes: A retrospective cohort study using Japanese health check-up data.
    PLoS One. 2021;16:e0257352.
    >> Share

  194. STARITZBICHLER R, Hunold P, Estrela-Lopis I, Hildebrand PW, et al
    Raman spectroscopy on blood serum samples of patients with end-stage liver disease.
    PLoS One. 2021;16:e0256045.
    >> Share

  195. FREISE C, Lee H, Chronowski C, Chan D, et al
    Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells.
    PLoS One. 2021;16:e0254557.
    >> Share

  196. GUO A, Mazumder NR, Ladner DP, Foraker RE, et al
    Predicting mortality among patients with liver cirrhosis in electronic health records with machine learning.
    PLoS One. 2021;16:e0256428.
    >> Share

  197. UHLIG M, Hein M, Habigt MA, Tolba RH, et al
    Acute myocardial injury secondary to severe acute liver failure: A retrospective analysis supported by animal data.
    PLoS One. 2021;16:e0256790.
    >> Share

  198. CHERCHI V, Vetrugno L, Terrosu G, Zanini V, et al
    Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series.
    PLoS One. 2021;16:e0256786.
    >> Share

  199. QUECK A, Uschner FE, Ferstl PG, Schulz M, et al
    Role of circulating angiogenin levels in portal hypertension and TIPS.
    PLoS One. 2021;16:e0256473.
    >> Share

  200. GARCIA-CHAVEZ JN, Vasquez-Garzon VR, Lopez MG, Villa-Trevino S, et al
    Integration of chronological omics data reveals mitochondrial regulatory mechanisms during the development of hepatocellular carcinoma.
    PLoS One. 2021;16:e0256016.
    >> Share

  201. MARINI TJ, Oppenheimer DC, Baran TM, Rubens DJ, et al
    Testing telediagnostic right upper quadrant abdominal ultrasound in Peru: A new horizon in expanding access to imaging in rural and underserved areas.
    PLoS One. 2021;16:e0255919.
    >> Share

  202. GIM JA, Bang SM, Lee YS, Lee Y, et al
    Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression.
    PLoS One. 2021;16:e0255822.
    >> Share

  203. BI J, Guo Y, Li Q, Liu L, et al
    Role of long intergenic non-protein coding RNA 01857 in hepatocellular carcinoma malignancy via the regulation of the microRNA-197-3p/anterior GRadient 2 axis.
    PLoS One. 2021;16:e0258312.
    >> Share

  204. ALBAKHEET SS, Lee MJ, Yoon H, Shin HJ, et al
    Psoas muscle area and paraspinal muscle fat in children and young adults with or without obesity and fatty liver.
    PLoS One. 2021;16:e0259948.
    >> Share

  205. GORJI-BAHRI G, Moradtabrizi N, Hashemi A
    Uncovering the stability status of the reputed reference genes in breast and hepatic cancer cell lines.
    PLoS One. 2021;16:e0259669.
    >> Share

  206. BULUT G, Guner Oytun M, Almuradova E, Harman M, et al
    Contribution of "complete response to treatment" to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis.
    PLoS One. 2021;16:e0259622.
    >> Share

  207. SCHOLER D, Castoldi M, Jordens MS, Schulze-Hagen M, et al
    Enlarged extracellular vesicles are a negative prognostic factor in patients undergoing TACE for primary or secondary liver cancer-a case series.
    PLoS One. 2021;16:e0255983.
    >> Share

  208. MAREK G, Collinsworth A, Liu C, Brantly M, et al
    Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens.
    PLoS One. 2021;16:e0256117.
    >> Share

  209. LEE SW, Kim SM, Hur W, Kang BY, et al
    Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway.
    PLoS One. 2021;16:e0261067.
    >> Share

  210. RADY B, Nishio T, Dhar D, Liu X, et al
    PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.
    PLoS One. 2021;16:e0260721.
    >> Share

  211. SVECIC A, Mansour R, Tang A, Kadoury S, et al
    Prediction of post transarterial chemoembolization MR images of hepatocellular carcinoma using spatio-temporal graph convolutional networks.
    PLoS One. 2021;16:e0259692.
    >> Share

  212. KUANG L, Zhou W, Jiang Y
    Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis.
    PLoS One. 2021;16:e0260479.
    >> Share

  213. HAN JW, Sung PS, Jang JW, Choi JY, et al
    Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma.
    PLoS One. 2021;16:e0260311.
    >> Share

  214. ESKRIDGE W, Vierling JM, Gosbee W, Wan GA, et al
    Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).
    PLoS One. 2021;16:e0260320.
    >> Share

  215. MOSTAFA RE, Shaffie NM, Allam RM
    Panax Ginseng alleviates thioacetamide-induced liver injury in ovariectomized rats: Crosstalk between inflammation and oxidative stress.
    PLoS One. 2021;16:e0260507.
    >> Share

  216. NAH EH, Cho S, Park H, Noh D, et al
    Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study.
    PLoS One. 2021;16:e0260477.
    >> Share

  217. GOYALE A, Jain A, Smith C, Papatheodoridi M, et al
    Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
    PLoS One. 2021;16:e0260313.
    >> Share

  218. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    >> Share

  219. TAKASU C, Yamashita S, Morine Y, Yoshikawa K, et al
    The role of the immunoescape in colorectal cancer liver metastasis.
    PLoS One. 2021;16:e0259940.
    >> Share

  220. NAKAGOMI R, Tateishi R, Mikami S, Wake T, et al
    Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics.
    PLoS One. 2021;16:e0259641.
    >> Share

  221. ABDEL-RAHMAN RF, Fayed HM, Asaad GF, Ogaly HA, et al
    The involvement of TGF-beta1 /FAK/alpha-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats.
    PLoS One. 2021;16:e0260130.
    >> Share

  222. BARTON JC, Barton JC, Patel N, McLaren GD, et al
    Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
    PLoS One. 2021;16:e0261690.
    >> Share

  223. AGBALAJOBI OM, Gmelin T, Moon AM, Alexandre W, et al
    Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action.
    PLoS One. 2021;16:e0261377.
    >> Share

  224. HAN YM, Lee J, Choi JM, Kwak MS, et al
    The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.
    PLoS One. 2021;16:e0260994.
    >> Share

  225. DERMAUW V, Muchai J, Al Kappany Y, Fajardo Castaneda AL, et al
    Human fascioliasis in Africa: A systematic review.
    PLoS One. 2021;16:e0261166.
    >> Share

  226. GROSS M, Spektor M, Jaffe A, Kucukkaya AS, et al
    Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging.
    PLoS One. 2021;16:e0260630.
    >> Share

  227. BOBARDT M, Ramirez CM, Baum MM, Ure D, et al
    The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance.
    PLoS One. 2021;16:e0251934.
    >> Share

  228. THOMAS JN, Roopkumar J, Patel T
    Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study.
    PLoS One. 2021;16:e0260098.
    >> Share

  229. FRUNDT T, Kuballa L, Lutgehetman M, Norz D, et al
    Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic.
    PLoS One. 2021;16:e0258450.
    >> Share

    January 2020
  230. KLEIN WM, Sonnemans LJP, Franckenberg S, Fliss B, et al
    Pseudolesion in the right parafissural liver parenchyma on CT: The base is found in embryology and collagen content.
    PLoS One. 2020;15:e0221544.
    >> Share

  231. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    >> Share

  232. JUN BG, Lee WC, Jang JY, Jeong SW, et al
    Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection.
    PLoS One. 2020;15:e0227440.
    >> Share

  233. LIN Y, Li H, Jin C, Wang H, et al
    The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227358.
    >> Share

  234. RAHMAN MM, Zhang C, Swe KT, Rahman MS, et al
    Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis.
    PLoS One. 2020;15:e0227565.
    >> Share

  235. DU S, Yang JZ, Chen J, Zhou WG, et al
    Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.
    PLoS One. 2020;15:e0227242.
    >> Share

  236. HAUBOLD J, Ludwig JM, Li Y, Buechter M, et al
    Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization.
    PLoS One. 2020;15:e0227972.
    >> Share

  237. MATSUMOTO M, Yashiro H, Ogino H, Aoyama K, et al
    Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.
    PLoS One. 2020;15:e0228212.
    >> Share

  238. RAIGANI S, Karimian N, Huang V, Zhang AM, et al
    Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
    PLoS One. 2020;15:e0228011.
    >> Share

  239. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    >> Share

  240. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0219412.
    >> Share

  241. ARTHUIS C, Diguisto C, Lorphelin H, Dochez V, et al
    Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study.
    PLoS One. 2020;15:e0228213.
    >> Share

  242. YANG B, Liang J, Qu Z, Yang F, et al
    Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
    PLoS One. 2020;15:e0227475.
    >> Share

  243. LANZA E, Muglia R, Bolengo I, Poretti D, et al
    Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
    PLoS One. 2020;15:e0227711.
    >> Share

  244. SEO JY, Lee JE, Chung GE, Shin E, et al
    A genome-wide association study on liver enzymes in Korean population.
    PLoS One. 2020;15:e0229374.
    >> Share

  245. DIAZ-RIVERA A, Meza-Rios A, Chagoya de Sanchez V, Velasco-Loyden G, et al
    Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats.
    PLoS One. 2020;15:e0228729.
    >> Share

  246. VAZQUEZ C, Gonzalez ML, Ferraris A, Bandi JC, et al
    Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia.
    PLoS One. 2020;15:e0228486.
    >> Share

  247. DINIZ MFHS, Beleigoli AMR, Bensenor IM, Lotufo PA, et al
    Association between TSH levels within the reference range and adiposity markers at the baseline of the ELSA-Brasil study.
    PLoS One. 2020;15:e0228801.
    >> Share

  248. LIANG X, Shu W, Linyong Z, Jianshui L, et al
    Preoperative nutritional evaluation of patients with hepatic alveolar echinococcosis.
    PLoS One. 2020;15:e0229396.
    >> Share

  249. CHANG TS, Tsai YH, Lin YH, Chen CH, et al
    Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding.
    PLoS One. 2020;15:e0229101.
    >> Share

  250. GIANNELLI G, Santoro A, Kelley RK, Gane E, et al
    Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-betaRI inhibitor galunisertib.
    PLoS One. 2020;15:e0222259.
    >> Share

  251. ZHANG J, Chen G, Zhang P, Zhang J, et al
    The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0228857.
    >> Share

  252. KELLER LM, Eighmy S, Li C, Winter L, et al
    Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.
    PLoS One. 2020;15:e0228985.
    >> Share

  253. DING W, Tan Y, Qian Y, Xue W, et al
    First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials.
    PLoS One. 2020;15:e0229492.
    >> Share

  254. MOON AM, Jiang Y, Rogal SS, Becker J, et al
    In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge.
    PLoS One. 2020;15:e0229497.
    >> Share

  255. LIN N, Li J, Ke Q, Xin F, et al
    Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review.
    PLoS One. 2020;15:e0229870.
    >> Share

  256. CHOI J, Lee D, Shim JH, Kim KM, et al
    Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229696.
    >> Share

  257. WARD MD, King MA, Gabrial C, Kenefick RW, et al
    Biochemical recovery from exertional heat stroke follows a 16-day time course.
    PLoS One. 2020;15:e0229616.
    >> Share

  258. MITCHELL RA, Rathi S, Dahiya M, Zhu J, et al
    Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey.
    PLoS One. 2020;15:e0229070.
    >> Share

  259. YANG G, Zhang M, Zhao Y, Pan Y, et al
    HNF-4alpha inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
    PLoS One. 2020;15:e0230450.
    >> Share

  260. DIEDRICH T, Kummer S, Galante A, Drolz A, et al
    Characterization of the immune cell landscape of patients with NAFLD.
    PLoS One. 2020;15:e0230307.
    >> Share

  261. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.
    PLoS One. 2020;15:e0230005.
    >> Share

  262. HEINTZ MM, McRee R, Kumar R, Baldwin WS, et al
    Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    PLoS One. 2020;15:e0229896.
    >> Share

  263. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    >> Share

  264. OKUBO H, Ando H, Ishizuka K, Kitagawa R, et al
    Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229772.
    >> Share

  265. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    >> Share

  266. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    >> Share

  267. LIU YW, Lin CC, Yong CC, Wang CC, et al
    Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center.
    PLoS One. 2020;15:e0230897.
    >> Share

  268. LI S, Feng X, Cao G, Wang Q, et al
    Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0230879.
    >> Share

  269. ZHANG F, Zhu Y, Wu S, Hou G, et al
    MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration.
    PLoS One. 2020;15:e0230716.
    >> Share

  270. MIKHAIL AS, Mauda-Havakuk M, Partanen A, Karanian JW, et al
    Liver-specific 3D sectioning molds for correlating in vivo CT and MRI with tumor histopathology in woodchucks (Marmota monax).
    PLoS One. 2020;15:e0230794.
    >> Share

  271. ABID A, Subhani F, Kayani F, Awan S, et al
    Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan.
    PLoS One. 2020;15:e0231398.
    >> Share

  272. FUCHIGAMI A, Imai Y, Uchida Y, Uchiya H, et al
    Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome.
    PLoS One. 2020;15:e0231427.
    >> Share

  273. PIEL S, Chamkha I, Dehlin AK, Ehinger JK, et al
    Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdose.
    PLoS One. 2020;15:e0231173.
    >> Share

  274. YU S, Wang Y, Hou J, Li W, et al
    Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.
    PLoS One. 2020;15:e0231003.
    >> Share

  275. HAUKELAND JW, Smastuen MC, Palsdatter PP, Ismail M, et al
    Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway.
    PLoS One. 2020;15:e0230263.
    >> Share

  276. ZHANG M, Haughey M, Wang NY, Blease K, et al
    Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs.
    PLoS One. 2020;15:e0229445.
    >> Share

  277. KIRINO S, Tsuchiya K, Kurosaki M, Kaneko S, et al
    Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0231828.
    >> Share

  278. LIU Y, Gao H, He YD
    A compound attributes-based predictive model for drug induced liver injury in humans.
    PLoS One. 2020;15:e0231252.
    >> Share

  279. WU YH, Wu CY, Cheng CY, Tsai SF, et al
    Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography.
    PLoS One. 2020;15:e0231264.
    >> Share

  280. SCHOMAKER S, Potter D, Warner R, Larkindale J, et al
    Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
    PLoS One. 2020;15:e0229753.
    >> Share

  281. NAKANO D, Kawaguchi T, Iwamoto H, Hayakawa M, et al
    Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT).
    PLoS One. 2020;15:e0232283.
    >> Share

  282. SAITO K, Fukasawa M, Shirasago Y, Suzuki R, et al
    Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero.
    PLoS One. 2020;15:e0232274.
    >> Share

  283. DAVIDSON CQ, Tharmalingam S, Niccoli S, Nemec-Bakk A, et al
    Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue.
    PLoS One. 2020;15:e0231650.
    >> Share

  284. BENZ F, Bogen A, Praktiknjo M, Jansen C, et al
    Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis.
    PLoS One. 2020;15:e0231701.
    >> Share

  285. SATAPATHY SK, Gonzalez HC, Vanatta J, Dyer A, et al
    A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    PLoS One. 2020;15:e0232006.
    >> Share

  286. RAIGANI S, Carroll C, Griffith S, Pendexter C, et al
    Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content.
    PLoS One. 2020;15:e0232886.
    >> Share

  287. CAPUTO F, Dadduzio V, Tovoli F, Bertolini G, et al
    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
    PLoS One. 2020;15:e0232449.
    >> Share

  288. WELBERRY C, Macdonald I, McElveen J, Parsy-Kowalska C, et al
    Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0232247.
    >> Share

  289. YU Y, Bai M, Ma F, Zhang W, et al
    Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    PLoS One. 2020;15:e0232516.
    >> Share

  290. PETZOLD G, Lasser J, Ruhl J, Bremer SCB, et al
    Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease.
    PLoS One. 2020;15:e0231044.
    >> Share

  291. GRIMALDI M, Palisi A, Marino C, Montoro P, et al
    NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?
    PLoS One. 2020;15:e0231506.
    >> Share

  292. SI H, Genna B, Zhuang X, Wang J, et al
    DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells.
    PLoS One. 2020;15:e0231466.
    >> Share

  293. KANG JK, Heo S, Kim HP, Song SH, et al
    Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    PLoS One. 2020;15:e0232754.
    >> Share

  294. WANG Y, Zhou X, Zhao D, Wang X, et al
    Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes.
    PLoS One. 2020;15:e0232630.
    >> Share

  295. LANZA E, Masetti C, Messana G, Muglia R, et al
    Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0232371.
    >> Share

  296. MASUYA T, Suzuki M, Tsujimura J, Kanamori S, et al
    Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice.
    PLoS One. 2020;15:e0233087.
    >> Share

  297. CHEN L, Zhang L, Wang W, Qiu W, et al
    Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
    PLoS One. 2020;15:e0232972.
    >> Share

  298. BELAUNZARAN-ZAMUDIO PF, Caro-Vega Y, Giganti MJ, Castilho JL, et al
    Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America.
    PLoS One. 2020;15:e0233965.
    >> Share

  299. NGUYEN TN, Nguyen HQ, Le DH
    Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
    PLoS One. 2020;15:e0229276.
    >> Share

  300. NAGATA S, Ozawa F, Nie M, Takeuchi S, et al
    3D culture of functional human iPSC-derived hepatocytes using a core-shell microfiber.
    PLoS One. 2020;15:e0234441.
    >> Share

  301. CHU YW, Chien CH, Sung MI, Chen CW, et al
    dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.
    PLoS One. 2020;15:e0234084.
    >> Share

  302. LI C, Ge S, Zhou J, Peng J, et al
    Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
    PLoS One. 2020;15:e0234062.
    >> Share

  303. BAEZA-RAJA B, Goodyear A, Liu X, Lam K, et al
    Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.
    PLoS One. 2020;15:e0234038.
    >> Share

  304. ALBAKHEET SS, Yoon H, Shin HJ, Koh H, et al
    Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0234096.
    >> Share

  305. MULEY M, Vespasiani-Gentilucci U, De Vincentis A, Santonico M, et al
    Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study.
    PLoS One. 2020;15:e0233350.
    >> Share

  306. STOCKHOFF L, Schultalbers M, Tergast TL, Hinrichs JB, et al
    Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
    PLoS One. 2020;15:e0235199.
    >> Share

  307. HAYASHI H, Yamashita YI, Okabe H, Imai K, et al
    Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy.
    PLoS One. 2020;15:e0234919.
    >> Share

  308. CHANDRASHEKAR DS, Golonka RM, Yeoh BS, Gonzalez DJ, et al
    Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    PLoS One. 2020;15:e0234726.
    >> Share

  309. QIAO C, Qian H, Wang J, Zhao T, et al
    PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells.
    PLoS One. 2020;15:e0234708.
    >> Share

  310. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    >> Share

  311. KOCH C, Bette T, Waidmann O, Filmann N, et al
    AFP ratio predicts HCC recurrence after liver transplantation.
    PLoS One. 2020;15:e0235576.
    >> Share

  312. COHEN AM, Chamberlin S, Deloughery T, Nguyen M, et al
    Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    PLoS One. 2020;15:e0235574.
    >> Share

  313. NICHOLS PH, Pan Y, May B, Pavlicova M, et al
    Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.
    PLoS One. 2020;15:e0234985.
    >> Share

  314. SZUCS A, Paku S, Sebestyen E, Nagy P, et al
    Postnatal, ontogenic liver growth accomplished by biliary/oval cell proliferation and differentiation.
    PLoS One. 2020;15:e0233736.
    >> Share

  315. FORTEA JI, Puerto M, Fernandez-Mena C, Asensio I, et al
    Sevoflurane versus ketamine+diazepam anesthesia for assessing systemic and hepatic hemodynamics in rats with non-cirrhotic portal hypertension.
    PLoS One. 2020;15:e0233778.
    >> Share

  316. NUDISCHER R, Renggli K, Hierlemann A, Roth AB, et al
    Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity.
    PLoS One. 2020;15:e0235745.
    >> Share

  317. WANG J, Shen P, Liao S, Duan L, et al
    Selenoprotein P inhibits cell proliferation and ROX production in HCC cells.
    PLoS One. 2020;15:e0236491.
    >> Share

  318. KRISS M, Golden-Mason L, Kaplan J, Mirshahi F, et al
    Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.
    PLoS One. 2020;15:e0236353.
    >> Share

  319. GOURRONC FA, Markan KR, Kulhankova K, Zhu Z, et al
    Pdgfralpha-Cre mediated knockout of the aryl hydrocarbon receptor protects mice from high-fat diet induced obesity and hepatic steatosis.
    PLoS One. 2020;15:e0236741.
    >> Share

  320. DIESINGER T, Buko V, Lautwein A, Dvorsky R, et al
    Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2020;15:e0235990.
    >> Share

  321. OKUSHIN K, Tsutsumi T, Ikeuchi K, Kado A, et al
    Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    PLoS One. 2020;15:e0234750.
    >> Share

  322. PELTONEN R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al
    Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    PLoS One. 2020;15:e0236569.
    >> Share

  323. YASUI D, Yamane A, Itoh H, Kobayashi M, et al
    In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
    PLoS One. 2020;15:e0222553.
    >> Share

  324. STEMMER A, Shadmi R, Bregman-Amitai O, Chettrit D, et al
    Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST).
    PLoS One. 2020;15:e0236021.
    >> Share

  325. SHEN Q, Hu G, Wu J, Lv L, et al
    A new clinical prognostic nomogram for liver cancer based on immune score.
    PLoS One. 2020;15:e0236622.
    >> Share

  326. YOO JJ, Lim YS, Kim MS, Lee B, et al
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
    PLoS One. 2020;15:e0236506.
    >> Share

  327. RASHIDI-ALAVIJEH J, Ceylan AS, Wedemeyer H, Kleefisch M, et al
    Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis.
    PLoS One. 2020;15:e0236528.
    >> Share

  328. SERPER M, Vujkovic M, Kaplan DE, Carr RM, et al
    Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    PLoS One. 2020;15:e0237430.
    >> Share

  329. FUKUDA H, Sato D, Moriwaki K, Ishida H, et al
    Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0237316.
    >> Share

  330. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    >> Share

  331. CHEN K, Sng WK, Quah JH, Liu J, et al
    Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    PLoS One. 2020;15:e0236977.
    >> Share

  332. FORLANO R, Mullish BH, Mukherjee SK, Nathwani R, et al
    In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.
    PLoS One. 2020;15:e0240400.
    >> Share

  333. SOGABE M, Okahisa T, Kurihara T, Takehara M, et al
    Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    PLoS One. 2020;15:e0238388.
    >> Share

  334. TAMAI Y, Iwasa M, Eguchi A, Shigefuku R, et al
    Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma.
    PLoS One. 2020;15:e0237370.
    >> Share

  335. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    >> Share

  336. LIRA MMP, de Medeiros Filho JEM, Baccin Martins VJ, da Silva G, et al
    Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study.
    PLoS One. 2020;15:e0237360.
    >> Share

  337. RONDA OAHO, van de Heijning BJM, de Bruin A, Thomas RE, et al
    Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet.
    PLoS One. 2020;15:e0232069.
    >> Share

  338. LEE J, Vali Y, Boursier J, Duffin K, et al
    Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238717.
    >> Share

  339. ROGAL SS, Yakovchenko V, Gonzalez R, Park A, et al
    Characterizing patient-reported outcomes in veterans with cirrhosis.
    PLoS One. 2020;15:e0238712.
    >> Share

  340. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    >> Share

  341. RAJCIC D, Brandt A, Jin CJ, Sanchez V, et al
    Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    PLoS One. 2020;15:e0237946.
    >> Share

  342. STRADOMSKA TJ, Syczewska M, Jamroz E, Pleskaczynska A, et al
    Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.
    PLoS One. 2020;15:e0238796.
    >> Share

  343. CORREA F, Hidalgo C, Stoore C, Jimenez M, et al
    Cattle co-infection of Echinococcus granulosus and Fasciola hepatica results in a different systemic cytokine profile than single parasite infection.
    PLoS One. 2020;15:e0238909.
    >> Share

  344. MAUNG K, Ramalingam S, Chaudhry M, Ren Y, et al
    Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.
    PLoS One. 2020;15:e0238824.
    >> Share

  345. GRIFFETT K, Bedia-Diaz G, Elgendy B, Burris TP, et al
    REV-ERB agonism improves liver pathology in a mouse model of NASH.
    PLoS One. 2020;15:e0236000.
    >> Share

  346. SANTOIEMMA PP, Dakwar O, Angarone MP
    A retrospective analysis of cases of Spontaneous Bacterial Peritonitis in cirrhosis patients.
    PLoS One. 2020;15:e0239470.
    >> Share

  347. LOOSEN SH, Wirtz TH, Roy S, Vucur M, et al
    Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0239386.
    >> Share

  348. WANG S, Toy M, Hang Pham TT, So S, et al
    Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
    PLoS One. 2020;15:e0239393.
    >> Share

  349. KANEKO S, Kurosaki M, Nagata K, Taki R, et al
    Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity.
    PLoS One. 2020;15:e0241663.
    >> Share

  350. PENG J, Zhou M, Chen C, Xie X, et al
    Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms.
    PLoS One. 2020;15:e0239266.
    >> Share

  351. CHOI JW, Lee JM, Lee DH, Yoon JH, et al
    Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study.
    PLoS One. 2020;15:e0239733.
    >> Share

  352. REY R M, Delgado AF, De Zubiria A, Pinto R, et al
    Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia.
    PLoS One. 2020;15:e0239834.
    >> Share

  353. RIEXINGER A, Laun FB, Bickelhaupt S, Seuss H, et al
    On the dependence of the cardiac motion artifact on the breathing cycle in liver diffusion-weighted imaging.
    PLoS One. 2020;15:e0239743.
    >> Share

  354. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    >> Share

  355. GOODSON ML, Knotts TA, Campbell EL, Snyder CA, et al
    Specific ablation of the NCoR corepressor delta splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.
    PLoS One. 2020;15:e0241238.
    >> Share

  356. KIM MC, Lee JI, Kim JH, Kim HJ, et al
    Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0240195.
    >> Share

  357. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    >> Share

  358. HASSAN S, Peluso J, Chalhoub S, Idoux Gillet Y, et al
    Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1alpha and MDR1.
    PLoS One. 2020;15:e0240676.
    >> Share

  359. LIN YJ, Lin CN, Sedghi T, Hsu SH, et al
    Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan.
    PLoS One. 2020;15:e0240542.
    >> Share

  360. ZHANG L, Yuan Q, Xu Y, Wang W, et al
    Comparative clinical outcomes of robot-assisted liver resection versus laparoscopic liver resection: A meta-analysis.
    PLoS One. 2020;15:e0240593.
    >> Share

  361. CHURCH RJ, Schomaker SJ, Eaddy JS, Boucher GG, et al
    Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.
    PLoS One. 2020;15:e0240562.
    >> Share

  362. YAN B, Luo J, Kaltenmeier C, Du Q, et al
    Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting beta-catenin in mice.
    PLoS One. 2020;15:e0239119.
    >> Share

  363. GRANATA V, Fusco R, Avallone A, Cassata A, et al
    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.
    PLoS One. 2020;15:e0241431.
    >> Share

  364. BAUMLER W, Schicho A, Schaible J, Verloh N, et al
    Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
    PLoS One. 2020;15:e0242093.
    >> Share

  365. ZHAO Y, Zhu C, Chang Q, Peng P, et al
    MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
    PLoS One. 2020;15:e0242179.
    >> Share

  366. GUO B, Tan X, Cen H
    EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma.
    PLoS One. 2020;15:e0242191.
    >> Share

  367. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    >> Share

  368. CHEN HY, Lu SN, Hung CH, Wang JH, et al
    Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.
    PLoS One. 2020;15:e0242113.
    >> Share

  369. GALIERO R, Pafundi PC, Simeon V, Rinaldi L, et al
    Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.
    PLoS One. 2020;15:e0243700.
    >> Share

  370. VISARIA A, Pai S, Fayngersh A, Kothari N, et al
    Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study.
    PLoS One. 2020;15:e0242431.
    >> Share

  371. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    >> Share

  372. PARK JH, Chung YE, Seo N, Choi JY, et al
    Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.
    PLoS One. 2020;15:e0242344.
    >> Share

  373. CHOI J, Kim SH, Han S, Lee D, et al
    A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma.
    PLoS One. 2020;15:e0241808.
    >> Share

  374. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    >> Share

  375. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    >> Share

  376. LEUNG CCT, Wong CKC
    Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration.
    PLoS One. 2020;15:e0241932.
    >> Share

  377. PALLADINI G, Ferrigno A, Di Pasqua LG, Berardo C, et al
    Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0243179.
    >> Share

  378. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    >> Share

  379. HIROSE S, Matsumoto K, Tatemichi M, Tsuruya K, et al
    Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients.
    PLoS One. 2020;15:e0241770.
    >> Share

  380. XIAO C, Fu X, Wang Y, Liu H, et al
    Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
    PLoS One. 2020;15:e0243812.
    >> Share

  381. ADHYAPOK P, Fu X, Sluka JP, Clendenon SG, et al
    A computational model of liver tissue damage and repair.
    PLoS One. 2020;15:e0243451.
    >> Share

  382. BRAUNWARTH E, Rumpf B, Primavesi F, Pereyra D, et al
    Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study.
    PLoS One. 2020;15:e0243539.
    >> Share

  383. LEE S, Kim JH, Moon H, Lee HJ, et al
    Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
    PLoS One. 2020;15:e0243815.
    >> Share

  384. BAYOUMI A, Jalil I, Metwally M, Adams LA, et al
    Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
    PLoS One. 2020;15:e0243590.
    >> Share

  385. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    >> Share

  386. SOHN W, Ham CB, Kim NH, Kim HJ, et al
    Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2020;15:e0243780.
    >> Share

  387. YEN FS, Lai JN, Wei JC, Chiu LT, et al
    Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis.
    PLoS One. 2020;15:e0243783.
    >> Share

  388. YUAN Y, Naito H, Kitamori K, Hashimoto S, et al
    The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension.
    PLoS One. 2020;15:e0243846.
    >> Share

  389. WANG G, Wang Q, Bai J, Li G, et al
    RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment.
    PLoS One. 2020;15:e0243640.
    >> Share

  390. LIU L, Liu C, Zhao M, Zhang Q, et al
    The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist GFT505 in CDAHFD-induced NASH model.
    PLoS One. 2020;15:e0243911.
    >> Share

  391. MANJARIN R, Maj MA, La Frano MR, Glanz H, et al
    %polynova_2way: A SAS macro for implementation of mixed models for metabolomics data.
    PLoS One. 2020;15:e0244013.
    >> Share

  392. HSIEH MH, Kao TY, Hsieh TH, Kao CC, et al
    Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
    PLoS One. 2020;15:e0244293.
    >> Share

  393. WEISSINGER M, Vogel J, Kupferschlager J, Dittmann H, et al
    Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
    PLoS One. 2020;15:e0244235.
    >> Share

  394. RYU H, Kim JH, Lee S, Han JK, et al
    Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.
    PLoS One. 2020;15:e0244304.
    >> Share

  395. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    >> Share

  396. BORTOLAMI M, Comparato A, Benna C, Errico A, et al
    Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.
    PLoS One. 2020;15:e0244356.
    >> Share

  397. HAYASHI T, Shibata M, Oe S, Miyagawa K, et al
    C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib.
    PLoS One. 2020;15:e0244370.
    >> Share

  398. THULUVATH PJ, Amjad W, Zhang T
    Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics.
    PLoS One. 2020;15:e0244744.
    >> Share

  399. PILLING D, Karhadkar TR, Gomer RH
    A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.
    PLoS One. 2020;15:e0244762.
    >> Share

    January 2019
  400. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    >> Share

  401. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
    PLoS One. 2019;14:e0226375.
    >> Share

  402. ERKAN B, Meier J, Clark TJ, Kaplan J, et al
    Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
    PLoS One. 2019;14:e0226291.
    >> Share

  403. ABBASS MA, Ahmad SA, Mahalingam N, Krothapalli KS, et al
    In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor.
    PLoS One. 2019;14:e0226001.
    >> Share

  404. SU RC, Lad A, Breidenbach JD, Blomquist TM, et al
    Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2019;14:e0225604.
    >> Share

  405. ZHONG GC, Liu S, Wu YL, Xia M, et al
    ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population.
    PLoS One. 2019;14:e0225792.
    >> Share

  406. SCOTT C, Stokes R, Cha KM, Clouston A, et al
    Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.
    PLoS One. 2019;14:e0225332.
    >> Share

  407. WELDEAREGAY KT, Gebrekidan MG, Gezahegne AA
    Health impact of hepatic-venous-occlusive disease in a small town in Ethiopia-Case study from Tahtay koraro district in Tigray region, 2017.
    PLoS One. 2019;14:e0224659.
    >> Share

  408. SENDRA L, Herrero MJ, Montalva EM, Noguera I, et al
    Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation.
    PLoS One. 2019;14:e0224568.
    >> Share

  409. YANG S, Kwak S, Lee JH, Kang S, et al
    Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
    PLoS One. 2019;14:e0224626.
    >> Share

  410. BUCHER JN, Koenig M, Schoenberg MB, Crispin A, et al
    Liver transplantation in patients with a history of migration-A German single center comparative analysis.
    PLoS One. 2019;14:e0224116.
    >> Share

  411. BAJAJ JS, Fan S, Thacker LR, Fagan A, et al
    Serum and urinary metabolomics and outcomes in cirrhosis.
    PLoS One. 2019;14:e0223061.
    >> Share

  412. ISHIKAWA T, Sasaki R, Nishimura T, Aibe Y, et al
    A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.
    PLoS One. 2019;14:e0223153.
    >> Share

  413. LIU Y, Liu X, Wang Y, Yi C, et al
    Protective effect of lactobacillus plantarum on alcoholic liver injury and regulating of keap-Nrf2-ARE signaling pathway in zebrafish larvae.
    PLoS One. 2019;14:e0222339.
    >> Share

  414. LEVICK C, Phillips-Hughes J, Collier J, Banerjee R, et al
    Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
    PLoS One. 2019;14:e0221066.
    >> Share

  415. MIN-DEBARTOLO J, Schlerman F, Akare S, Wang J, et al
    Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    PLoS One. 2019;14:e0226854.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016